Waters Corporation (WAT)
Market Cap | 20.44B |
Revenue (ttm) | 2.96B |
Net Income (ttm) | 642.23M |
Shares Out | 59.20M |
EPS (ttm) | 10.84 |
PE Ratio | 31.76 |
Forward PE | 28.70 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 170,958 |
Open | 345.76 |
Previous Close | 345.19 |
Day's Range | 343.10 - 347.22 |
52-Week Range | 231.90 - 363.80 |
Beta | 0.93 |
Analysts | Hold |
Price Target | 291.45 (-15.33%) |
Earnings Date | May 7, 2024 |
About WAT
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies... [Read more]
Financial Performance
In 2023, Waters's revenue was $2.96 billion, a decrease of -0.52% compared to the previous year's $2.97 billion. Earnings were $642.23 million, a decrease of -9.26%.
Financial StatementsAnalyst Forecast
According to 12 analysts, the average rating for WAT stock is "Hold." The 12-month stock price forecast is $291.45, which is a decrease of -15.33% from the latest price.
News
Waters Streamlines and Expedites PFAS Testing with Innovative Oasis Dual-Phase Cartridges
News Summary: Waters Oasis™ Dual-phase PFAS Analysis Cartridges simplify sample preparation for EPA 1633 testing for analysis of PFAS concentrations in non-potable water, soils, biosolids, and tissue....
Waters Advances Battery Electrode Design and Performance Analysis with New Rheo-IS Accessory
News Summary: New Rheo-Impedance Spectroscopy (Rheo-IS) accessory enables battery scientists to better assess electrode slurry composition quality under real-world and process-relevant conditions. The...
Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule Characterization
News Summary: Waters now enables seamless connectivity between its liquid chromatography (LC) systems and multi-angle light-scattering instruments (MALS) for improved ease-of-use, efficiency, and data...
Waters Corporation to Present at the TD Cowen 44th Annual Health Care Conference
MILFORD, Mass. , Feb. 22, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D.
Waters Corp beats Q4 sales estimates on strong demand for drug development services
Waters Corp on Tuesday reported fourth-quarter sales ahead of Wall Street estimates, helped by demand for its services used in drug development.
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2023 Financial Results
Highlights Fourth Quarter 2023 Sales of $819 million declined 4.5% as reported and 8% in organic constant currency, in line with guidance Operational excellence drove gross margin expansion of 170 bas...
Waters Corporation Schedules Fourth Quarter 2023 Earnings Conference Call
MILFORD, Mass. , Jan. 18, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q4 2023 financial results conference call live on Tuesday, February 6th, 2024 at 8:00 a.m.
Waters Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
MILFORD, Mass., Dec. 21, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D.
Waters Earns Sustainability Designation from My Green Lab for Xevo TQ Absolute System
News Summary: My Green Lab awards ACT label to the Waters Xevo™ TQ Absolute system, providing independent validation for its sustainable manufacturing, packaging operation, and end-of-life. Laboratory...
Waters Corporation Named to Dow Jones Sustainability Index for the Third Consecutive Year
MILFORD, Mass. , Dec. 19, 2023 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced it has been named to the Dow Jones Sustainability North America Index (DJSI North America) for the third consecu...
Waters Corporation Board of Directors Named 2024 Public Company Board of the Year by National Association of Corporate Directors New England Chapter
MILFORD, Mass. , Dec. 18, 2023 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced that its Board of Directors has been named 2024 "Public Company Board of the Year" by the National Associa...
Waters Corporation Opens New State-of-the-Art Global Capability Center in Bengaluru, India
News Summary: Waters inaugurates Global Capability Center in Bengaluru's RMZ Ecoworld technology park with dignitaries from government, customers, partners, and employees. New US$16M (INR ₹1.3Bn) faci...
Waters Earns Top Score in Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index
News Summary: Waters recognized for its companywide policies and active commitment to LGBTQIA+ workplace equality and inclusion, scoring 100 on the Human Rights Campaign Foundation's 2023-2024 Corpora...
Waters Corporation to Present at the Evercore ISI HealthCONx 2023 Health Care Conference
MILFORD, Mass. , Nov. 16, 2023 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra Ph.D.
WATERS 2023 ESG REPORT HIGHLIGHTS CONTINUED PROGRESS TOWARDS SUSTAINABILITY COMMITMENTS
News Summary: Waters makes strong progress on its goal to reduce greenhouse gas emissions 35% by 2025 through greater use of renewable/low-carbon energy sources and further cutting Scope 1 and Scope 2...
Waters Corporation (NYSE: WAT) Reports Third Quarter 2023 Financial Results
Highlights Sales of $712 million grew less than 1% as reported and declined 4% in organic constant currency Low single-digit organic constant currency growth outside of China, led by mid-single-digit ...
Among the S&P 500, these 20 companies have made the best use of investors' money
There is no easy way to select individual stocks. Measures of financial quality can highlight companies that are worth a closer look, but a decision to commit money must also take into consideration b...
Waters Corporation Announces Business Unit Leadership Transition
Jonathan Pratt to Step Down to Pursue an External Opportunity Christos Ross Named Interim Senior Vice President of the Waters Division MILFORD, Mass. , Oct. 24, 2023 /PRNewswire/ -- Waters Corporation...
Waters Accelerates Oligonucleotide Bioanalysis with the Launch of OligoWorks™ SPE Workflow and Kits
News Summary: Delivers up to 2x[i] higher oligonucleotide recovery from biofluids with improved LC-MS sensitivity and reproducibility to support robust quantitation. Faster time-to-results for expande...
Waters Corporation Schedules Third Quarter 2023 Earnings Conference Call
MILFORD, Mass. , Oct. 10, 2023 /PRNewswire/ -- Waters Corporation (NYSE: WAT) will hold its Q3 2023 financial results conference call live on Tuesday, November 7th, 2023 at 8:00 a.m.
Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological Therapies
News Summary: New Zeta Star™ instrument for nanoparticle analysis from Wyatt Technology™ portfolio combines three light scattering techniques into a single device – cutting measurement time by up to 1...
Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media
News Summary: Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and Andrew+™ robot with upstream bioreactors to automate routine pr...
Waters Corporation to Present at the Bank of America Global Healthcare Conference 2023
MILFORD, Mass. , Aug. 30, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D.
Waters Corporation (NYSE: WAT) Reports Second Quarter 2023 Financial Results
Highlights Sales of $741 million grew 4% as reported and 3% in organic constant currency Strength led by double-digit growth in Industrial and Academic & Government Operational excellence added 230 ba...
Waters Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy Applications
News Summary: Reduces the cost of gene therapies by using 3-10x less sample than other methodsi while generating faster results and more drug substance information. XBridge Premier GTx BEH SEC columns...